文献速递免疫规划慢病防控与筛查卫生政策与健康促进

HPV单剂次接种在Gavi支持国家供应受限期间扩大可及性的作用

The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints.
PubMed 文献 · Vaccine · 2026-01-22

研究评估2023–2024年Gavi支持国家采用HPV单剂次接种对接种可及性和宫颈癌预防的影响。利用UNICEF发货计划和Gavi接种方案数据建模,结果显示单剂次策略可使更多女孩接种,并额外避免未来宫颈癌。

要点

  • 若充分利用供应,单剂次可额外避免37万未来宫颈癌。

核心结论

  • 在供应受限背景下,单剂次HPV接种策略对中低收入国家宫颈癌消除有实质性积极影响。

研究设计与样本

  • 基于UNICEF发货计划和Gavi接种方案信息,估算可覆盖女孩数并比较单剂次与两剂次情景。
  • 使用HPVsim微模拟模型校准各国数据,预测避免的宫颈癌数。

主要发现

  • 若充分利用供应,2023–2024年单剂次可额外避免最多37万(356,000–376,000)未来宫颈癌。

临床怎么用

  • 在HPV疫苗供应受限时,采用单剂次方案可扩大接种覆盖并加速宫颈癌预防。
  • 决策者可依据发货和接种数据评估单剂次策略的实际影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over 2023 and 2024, 19 of the countries that were supported by Gavi to purchase HPV vaccines adopted a single-dose HPV vaccination schedule. The goal of this study is to estimate the impact on vaccination access and the number of cervical cancers averted compared to a two-dose schedule. METHODS: We estimated the population that could be targeted in countries supported by Gavi to purchase HPV vaccines. We used UNICEF shipment plans to identify the number of HPV doses shipped to each country in 2023 and 2024, plus information supplied by Gavi on the dose schedule implemented in each country and year, adjusting for vaccine wastage. We computed the number of girls that could have been reached, first assuming complete utilization of all shipped doses under a single-dose schedule, and second assuming a counterfactual scenario where all countries would have used a 2-dose schedule. We then compared this to country-reported data on the number of girls actually vaccinated. For each of the three scenarios we modeled the number of cervical cancers averted using HPVsim, a microsimulation model calibrated to each country. FINDINGS: We calculate that the introduction of single-dose HPV vaccination in Gavi-supported countries would have allowed these countries to target 23.3M additional girls if all supply was utilized. Reported data on girls vaccinated indicates that in actuality an additional 18.5M girls were reached due to adoption of single-dose. We estimate that the use of single-dose schedule in 2023 and 2024 could have averted up to 370,000 (356,000-376,000) additional future cervical cancers if all supply had been utilized, and 297,000 (222,000-369,000) given actual utilization. INTERPRETATION: The single-dose HPV vaccination strategy has had a substantial positive impact on cervical cancer elimination in context of supply constraints affecting low and middle-income countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Stuart R, Theopold N, Miall N, et al. The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints. Vaccine. 2026. PMID: 41576708. doi:10.1016/j.vaccine.2025.128187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。